| Literature DB >> 32958383 |
Karl T Wagner1, Trevor R Nash2, Bohao Liu2, Gordana Vunjak-Novakovic3, Milica Radisic4.
Abstract
Strategies to regenerate cardiac tissue postinjury are limited and heart transplantation remains the only 'cure' for a failing heart. Extracellular vesicles (EVs), membrane-bound cell secretions important in intercellular signaling, have been shown to play a crucial role in regulating heart function. A mechanistic understanding of the role of EVs in the heart remains elusive due to the challenges in studying the native human heart. Tissue-on-a-chip platforms, comprising functional, physiologically relevant human tissue models, are an emerging technology that has yet to be fully applied to the study of EVs. In this review, we summarize recent advances in cardiac tissue-on-a-chip (CTC) platforms and discuss how they are uniquely situated to advance our understanding of EVs in cardiac disease and regeneration.Entities:
Keywords: cardiac tissue-on-a-chip; disease modeling; extracellular vesicles; intercellular signaling; regenerative cardiac therapy
Mesh:
Year: 2020 PMID: 32958383 PMCID: PMC7969481 DOI: 10.1016/j.tibtech.2020.08.005
Source DB: PubMed Journal: Trends Biotechnol ISSN: 0167-7799 Impact factor: 21.942